Foresite Capital Management V, LLC - Q3 2023 holdings

$62.7 Million is the total value of Foresite Capital Management V, LLC's 7 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 30.0% .

 Value Shares↓ Weighting
HIMS  Hims & Hers Health, Inc.$23,482,966
-33.1%
3,733,3810.0%37.46%
+46.2%
 Disc Medicine, Inc.$11,440,241
+5.8%
243,5130.0%18.25%
+131.1%
BuyTheseus Pharmaceuticals, Inc.$11,052,661
-67.0%
4,108,796
+14.6%
17.63%
-27.8%
ACRS  Aclaris Therapeutics, Inc.$8,618,965
-33.9%
1,258,2430.0%13.75%
+44.3%
KNTE  Kinnate Biopharma Inc.$4,936,340
-53.8%
3,525,9570.0%7.88%
+0.9%
CMPX SellCompass Therapeutics, Inc.$2,456,545
-41.7%
1,246,977
-5.8%
3.92%
+27.4%
PHVS SellPharvaris N.V.$691,674
+33.8%
33,142
-2.9%
1.10%
+192.1%
QSI ExitQuantum Si Inc$0-924,404
-100.0%
-1.21%
ExitSomalogic, Inc.$0-3,403,276
-100.0%
-5.74%
ExitPardes Biosciences Inc$0-10,811,887
-100.0%
-14.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Kinnate Biopharma Inc.12Q3 202325.8%
Hims & Hers Health, Inc.11Q3 202337.5%
Aclaris Therapeutics, Inc.11Q3 202315.4%
Pharvaris N.V.11Q3 20235.5%
Quantum-Si Incorporated9Q2 202311.3%
TheseusPharmaceuticals, Inc.8Q3 202324.4%
Somalogic, Inc.8Q2 202320.5%
Compass Therapeutics, Inc.8Q3 202317.2%
Pardes Biosciences Inc7Q2 202337.8%
Gemini Therapeutics, Inc.7Q3 20229.7%

View Foresite Capital Management V, LLC's complete holdings history.

Latest filings
TypeFiled
42024-04-05
13F-HR2024-02-13
13F-HR2023-11-13
42023-08-31
13F-HR2023-08-11
42023-07-19
13F-HR2023-05-12
42023-05-10
42023-04-06
42023-02-22

View Foresite Capital Management V, LLC's complete filings history.

Compare quarters

Export Foresite Capital Management V, LLC's holdings